COVID-19 in immunocompromised children and adolescents
Since coronavirus disease 2019 (COVID-19) became a global pandemic, concerns have arisen regarding the risks of COVID-19 in immunocompromised children and adolescents. Here we aimed to evaluate the clinical outcomes and risks of severe COVID-19 in immunocompromised pediatric patients. Previous studi...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
The Korean Pediatric Society
2023-05-01
|
| Series: | Clinical and Experimental Pediatrics |
| Subjects: | |
| Online Access: | http://www.e-cep.org/upload/pdf/cep-2022-00878.pdf |
| _version_ | 1797831788556451840 |
|---|---|
| author | Byung Ok Kwak Byung Wook Eun |
| author_facet | Byung Ok Kwak Byung Wook Eun |
| author_sort | Byung Ok Kwak |
| collection | DOAJ |
| description | Since coronavirus disease 2019 (COVID-19) became a global pandemic, concerns have arisen regarding the risks of COVID-19 in immunocompromised children and adolescents. Here we aimed to evaluate the clinical outcomes and risks of severe COVID-19 in immunocompromised pediatric patients. Previous studies reported that most children and adolescents receiving immunosuppressive medications have clinical presentations and favorable outcomes similar to those of the general pediatric population. Treatments and access to health services should not be interrupted in these populations, and continuous monitoring of the potential impact of variant strains on the risk of immunocompromised pediatric patients is warranted. |
| first_indexed | 2024-04-09T13:58:24Z |
| format | Article |
| id | doaj.art-f403c1d9f601428295c0f415d606aa4a |
| institution | Directory Open Access Journal |
| issn | 2713-4148 |
| language | English |
| last_indexed | 2024-04-09T13:58:24Z |
| publishDate | 2023-05-01 |
| publisher | The Korean Pediatric Society |
| record_format | Article |
| series | Clinical and Experimental Pediatrics |
| spelling | doaj.art-f403c1d9f601428295c0f415d606aa4a2023-05-08T00:43:51ZengThe Korean Pediatric SocietyClinical and Experimental Pediatrics2713-41482023-05-0166518218910.3345/cep.2022.0087820125555604COVID-19 in immunocompromised children and adolescentsByung Ok Kwak0Byung Wook Eun1 Department of Pediatrics, Hallym University Kangnam Sacred Heart Hospital, Seoul, Korea Department of Pediatrics, Nowon Eulji Medical Center, Eulji University School of Medicine, Seoul, KoreaSince coronavirus disease 2019 (COVID-19) became a global pandemic, concerns have arisen regarding the risks of COVID-19 in immunocompromised children and adolescents. Here we aimed to evaluate the clinical outcomes and risks of severe COVID-19 in immunocompromised pediatric patients. Previous studies reported that most children and adolescents receiving immunosuppressive medications have clinical presentations and favorable outcomes similar to those of the general pediatric population. Treatments and access to health services should not be interrupted in these populations, and continuous monitoring of the potential impact of variant strains on the risk of immunocompromised pediatric patients is warranted.http://www.e-cep.org/upload/pdf/cep-2022-00878.pdfcovid-19sars-cov-2immunocompromisedchildadolescent |
| spellingShingle | Byung Ok Kwak Byung Wook Eun COVID-19 in immunocompromised children and adolescents Clinical and Experimental Pediatrics covid-19 sars-cov-2 immunocompromised child adolescent |
| title | COVID-19 in immunocompromised children and adolescents |
| title_full | COVID-19 in immunocompromised children and adolescents |
| title_fullStr | COVID-19 in immunocompromised children and adolescents |
| title_full_unstemmed | COVID-19 in immunocompromised children and adolescents |
| title_short | COVID-19 in immunocompromised children and adolescents |
| title_sort | covid 19 in immunocompromised children and adolescents |
| topic | covid-19 sars-cov-2 immunocompromised child adolescent |
| url | http://www.e-cep.org/upload/pdf/cep-2022-00878.pdf |
| work_keys_str_mv | AT byungokkwak covid19inimmunocompromisedchildrenandadolescents AT byungwookeun covid19inimmunocompromisedchildrenandadolescents |